Grown Rogue International (GRUSF) Asset Writedowns and Impairment (2015 - 2025)
Grown Rogue International (GRUSF) posted quarterly Asset Writedowns and Impairment of $26715.0 for Q1 2025, up 1127.15% year-over-year from $2177.0 in Q1 2024, and up 367.15% quarter-over-quarter from -$10000.0 in Q3 2024.
Grown Rogue International (GRUSF) Asset Writedowns and Impairment (2015 - 2025) Analysis & Trends
Grown Rogue International's Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $26715.0 for Q1 2025.
- In Q1 2025, Asset Writedowns and Impairment rose 1127.15% year-over-year to $26715.0; the TTM figure through Jun 2025 stood at $16715.0 (down 90.93% YoY), while the FY2023 annual figure was $87699.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at $26715.0, up from -$10000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $168144.0 in Q1 2023, with the low at -$10000.0 in Q3 2024.
- The 4-year median for Asset Writedowns and Impairment is $13881.0 (2023), against an average of $53615.9.
- The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment soared 2590.3% in 2023, then soared 1127.15% in 2025.
- Grown Rogue International's Asset Writedowns and Impairment stood at $6250.0 in 2022, then soared by 122.1% to $13881.0 in 2023, then sank by 172.04% to -$10000.0 in 2024, then soared by 367.15% to $26715.0 in 2025.
- Business Quant data shows GRUSF's Asset Writedowns and Impairment at $26715.0 in Q1 2025, -$10000.0 in Q3 2024, and $2177.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 26,715.00 |
| Mar 31, 2025 | 26,715.00 |
| Sep 30, 2024 | -10,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Mar 31, 2024 | 2,177.00 |
| Mar 31, 2024 | 2,177.00 |
| Oct 31, 2023 | 13,881.00 |
| Oct 31, 2023 | 13,881.00 |
| Apr 30, 2023 | 168,144.00 |
| Apr 30, 2023 | 168,144.00 |
| Jan 31, 2023 | 168,144.00 |
| Jan 31, 2023 | 168,144.00 |
| Jan 31, 2022 | 6,250.00 |
| Jan 31, 2022 | 6,250.00 |
| Oct 31, 2020 | -962.00 |
| Oct 31, 2020 | -962.00 |
| Jul 31, 2020 | -12,433.00 |
| Jul 31, 2020 | -12,433.00 |
| Apr 30, 2020 | 10,370.00 |
| Apr 30, 2020 | 10,370.00 |